T0	Outcomes 304 324	locoregional control
T1	Outcomes 329 354	disease specific survival
T2	Outcomes 608 625	influence of EGFr
T3	Outcomes 630 663	histopathological differentiation
T4	Outcomes 673 711	overall treatment time of radiotherapy
T5	Outcomes 1079 1088	responded
T6	Outcomes 1276 1298	tumor differentiation.
T7	Outcomes 1362 1395	prominent separation of response:
T8	Outcomes 1436 1451	differentiation
T9	Outcomes 1694 1719	disease specific survival
T10	Outcomes 1826 1860	superior to conventional treatment
T11	Outcomes 1878 1886	response
T12	Outcomes 1933 1951	expression of EGFr
T13	Outcomes 1970 1992	tumor differentiation.